| Issue |
Med Sci (Paris)
Volume 34, Number 1, Janvier 2018
|
|
|---|---|---|
| Page(s) | 12 - 14 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/20183401003 | |
| Published online | 31 January 2018 | |
Nouvelle
La GTPase RhoB, un nouvel acteur de la résistance adaptative aux inhibiteurs de la tyrosine kinase du récepteur de l'EGF dans les cancers du poumon
The Ras-related GTPase RhoB, a relevant actor in the adaptive resistance to EGFR tyrosine kinase inhibitors in lung cancers
1
Inserm U1037, centre de recherches en cancérologie de Toulouse, université Paul Sabatier, F-31057, Toulouse, France
2
Institut Claudius Regaud, Institut universitaire du cancer-oncopole, F-31057, Toulouse, France
3
CHU de Toulouse, Institut universitaire du cancer - Rangueil Larrey, F-31057, Toulouse, France
*
favre.gilles@iuct-oncopole.fr
Cet article ne possède pas de résumé.
© 2018 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
